Screener
Pacific Biosciences of California PACB Free cash flow
Free cash flow at other companies
Other financials
Where this comes from
Calculated from Pacific Biosciences of California’s reported figures.
The source filing: Pacific Biosciences of California’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 5:30 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001299130-26-000122
FAQ
- What is Pacific Biosciences of California's free cash flow?
- Pacific Biosciences of California (PACB) reported free cash flow of -$37.14M in Q2 2026.
- How has Pacific Biosciences of California's free cash flow changed year-over-year?
- Pacific Biosciences of California's free cash flow decreased by 24.1% year-over-year, from -$29.93M to -$37.14M.
- What is the long-term trend for Pacific Biosciences of California's free cash flow?
- Over 4 years (2021 to 2025), Pacific Biosciences of California's free cash flow has grown at a -0.7% compound annual growth rate (CAGR), from -$117.11M to -$113.92M.
- What does free cash flow mean?
- Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.
Ask your AI about Pacific Biosciences of California's free cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude